Article info

Download PDFPDF

Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study

Authors

  1. Correspondence to Dr Takashi Taguchi; taguchi.takashi.ft{at}daiichisankyo.co.jp
View Full Text

Citation

Inagaki N, Chou HS, Tsukiyama S, et al
Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study

Publication history

  • Received March 28, 2017
  • Revised August 31, 2017
  • Accepted September 3, 2017
  • First published September 29, 2017.
Online issue publication 
September 29, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.